Market open
Accolade/$ACCD
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Accolade
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
Ticker
$ACCD
Sector
Trading on
Industry
Health Care Providers & Services
Headquarters
Employees
2,400
Website
Accolade Metrics
BasicAdvanced
$299M
Market cap
-
P/E ratio
-$1.04
EPS
1.99
Beta
-
Dividend rate
Price and volume
Market cap
$299M
Beta
1.99
52-week high
$15.36
52-week low
$3.08
Average daily volume
1.3M
Financial strength
Current ratio
2.72
Quick ratio
2.569
Long term debt to equity
54.775
Total debt to equity
56.446
Interest coverage (TTM)
-21.68%
Management effectiveness
Return on assets (TTM)
-7.27%
Return on equity (TTM)
-18.61%
Valuation
Price to revenue (TTM)
0.65
Price to book
0.7
Price to tangible book (TTM)
-108.08
Price to free cash flow (TTM)
-445.967
Growth
Revenue change (TTM)
16.04%
Earnings per share change (TTM)
-46.32%
3-year revenue growth (CAGR)
24.15%
3-year earnings per share growth (CAGR)
-26.90%
What the Analysts think about Accolade
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Accolade stock.
Accolade Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Accolade Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Accolade News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Accolade stock?
Accolade (ACCD) has a market cap of $299M as of November 22, 2024.
What is the P/E ratio for Accolade stock?
The price to earnings (P/E) ratio for Accolade (ACCD) stock is 0 as of November 22, 2024.
Does Accolade stock pay dividends?
No, Accolade (ACCD) stock does not pay dividends to its shareholders as of November 22, 2024.
When is the next Accolade dividend payment date?
Accolade (ACCD) stock does not pay dividends to its shareholders.
What is the beta indicator for Accolade?
Accolade (ACCD) has a beta rating of 1.99. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.